Articles

The Latest: On February 23 2024, the US FDA approved Simlandi (adalimumab-ryvk), a biosimilar to AbbVie’s blockbuster drug Humira (adalimumab). The approval marks a significant milestone for Teva and its partner, Alvotech, as Simlandi becomes the first high-concentration, citrate-free biosimilar to Humira with an interchangeability designation in

Key View

• Pharmaceutical legislation in Ukraine will align with the EU, benefitting stakeholders.
• Local pharmaceutical production will continue to increase, despite limitations from the war with Russia. 
• Foreign investment in Ukraine’s pharmaceutical industry will help to drive local sales.

Pharmaceutical legislation in Ukraine will align

Key View 

• As Russia’s economic isolation from the West increases, previously friendly neighbouring markets are finding the need to reconsider their relationships and allies.
• Notably, the Russia-Ukraine war has created new opportunities for markets along Russia’s periphery, due to shifting trade routes and outmigration from Russia. 
• Looking

Key View

• We anticipate that tensions between Rwanda and the Democratic Republic of the Congo (DRC) will remain elevated in the near term, but we maintain our core view that direct conflict between Rwandan and Congolese forces is unlikely.
• Less likely scenarios include limited conflict between the two states, as well as a broader regional

Key View: Switzerland's EV market is poised for continued expansion, supported by a well-developed charging infrastructure and a high-income consumer base. Anticipated policy shifts and a growing emphasis on e-mobility position the nation for a significant increase in EV adoption rates. We maintain an upbeat outlook for EV sales in Switzerland in

Key View

• Post-war Ukraine is anticipated to encounter social instability, as reconstruction efforts and funds are predicted to be unevenly allocated, favouring safer regions over those most affected by the conflict.
• Reintegrating demobilised soldiers into the civilian economy and regulating gun ownership will represent major challenges for

Key View 

• Political stability ahead of the elections in Austria will persist, especially now that early elections seem to be off the table. 
• The far-right Freedom of Austria Party continues to hold the best chances to win the general election, though coalition negotiations will proof a challenge for the right-wing populist party.
• We thus

Key View

• We forecast that the Nigerian economy will expand by 2.9% in 2024, following a higher-than-expected real GDP outturn of 3.5% y-o-y in Q423. 
• Multi decade-high inflation as a result of the partial removal of the fuel subsidy and exchange rate weakness will keep private consumption and fixed investment weak in 2024.
• That said, the

The Latest: On February 21 2024, the Israel-based cultivated proteins company Aleph Farms announced a partnership with Thailand-based bio-based products manufacturer BBGI and India-based Fermbox Bio, a synthetic biology research and manufacturing company. Amongst the many new initiatives, the partnership will primarily initiate the first cellular

Key View

• We expect that real GDP growth in Sierra Leone will accelerate to 3.0% in 2024 from an estimated 2.1% in 2023.
• This slight recovery in growth will be driven by moderating inflation, which will encourage private consumption.
• In 2025, we expect real GDP growth to accelerate to 4.2% as inflation reverts to pre-pandemic levels, and the